Added to YB: 2024-09-13
Pitch date: 2024-06-30
GKOS [bullish]
Glaukos Corporation
-3.79%
current return
Author Info
No bio for this author
Company Info
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.
Market Cap
$5.2B
Pitch Price
$118.24
Price Target
N/A
Dividend
N/A
EV/EBITDA
-102.02
P/E
-58.28
EV/Sales
10.65
Sector
Health Care Equipment and Supplies
Category
growth
Alger Weatherbie Specialized Growth Fund Portfolio Holding: Glaukos Corporation
GKOS: Ophthalmic med-tech co. pioneering MIGS. Q1 beats, raised FY rev guidance on iStent adoption. iDose launch could transform glaucoma treatment, reducing eye drops & surgeries. Potential for significant market share gains in large glaucoma market.
Read full article (1 min)